Single-lead Electrocardiogram Research Articles

Evaluation of the accuracy of a single-lead adhesive electrocardiogram patch monitoring device (S-PATCH3-Cardio) in patients post-myocardial infarction: a pilot study.

Evaluation of the accuracy of a single-lead adhesive electrocardiogram patch monitoring device (S-PATCH3-Cardio) in patients post-myocardial infarction: a pilot study.

Conv-RGNN: An efficient Convolutional Residual Graph Neural Network for ECG classification

Background and objective:Electrocardiogram (ECG) analysis is crucial in diagnosing cardiovascular diseases (CVDs). It is important to consider both temporal and spatial features in ECG analysis to improve automated CVDs diagnosis. Significant progress has been made in automated CVDs diagnosis based on ECG with the continuous development of deep learning. Current most researches often treat 12-lead ECG signals as synchronous sequences in Euclidean space, focusing primarily on extracting temporal features while overlooking the spatial relationships among the 12-lead. However, the spatial distribution of 12-lead ECG electrodes can be more naturally represented using non-Euclidean data structures, which makes the relationships among leads more consistent with their intrinsic characteristics. Methods:This study proposes an innovative method, Convolutional Residual Graph Neural Network (Conv-RGNN), for ECG classification. The first step is to segment the 12-lead ECG into twelve single-lead ECG, which are then mapped to nodes in a graph that captures the relationships between the different leads through spatial connections, resulting in the 12-lead ECG graph. The graph is then used as input for Conv-RGNN. A convolutional neural network with a position attention mechanism is used to extract temporal sequence information and selectively integrate contextual information to enhance semantic features at different positions. The spatial features of the 12-lead ECG graph are extracted using the residual graph neural network. Results:The experimental results indicate that Conv-RGNN is highly competitive in two multi-label datasets and one single-label dataset, demonstrating exceptional parameter efficiency, inference speed, model performance, and robustness. Conclusion:The Conv-RGNN proposed in this paper offer a promising and feasible approach for intelligent diagnosis in resource-constrained environments.

Intra- and Inter-Rater Reliability of Linear and Nonlinear Measures of Short-Term Heart Rate Variability Following Combat-Related Traumatic Injury.

Heart rate variability (HRV) is a marker of autonomic function. However, the reliability of short-term HRV measurement in individuals with combat-related traumatic injury (CRTI) remains undetermined. An intra- and inter-rater reliability study was conducted using a subsample (n = 35) of British servicemen with CRTI enrolled in the ongoing ADVANCE study. A five-minute epoch of single-lead electrocardiogram data collected during spontaneous breathing was used to measure HRV. HRV analyses were independently performed by two examiners using Kubios. Intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimum detectable change (MDC), and coefficient of variance were calculated for linear [root mean square of successive difference (RMSSD), standard deviation of NN interval, low-frequency, high-frequency, total power] and nonlinear (SD1-2, acceleration and deceleration capacities, sample entropy) measures. Bland-Altman %plots were used to assess bias in intra- and inter-rater HRV data. The mean age of participants was 39.3 ± 6.3 years. An excellent ICC score of 0.9998 (95% CI 0.9997, 0.9999) was observed for intra-rater analyses of RMSSD, and similar excellent ICC scores were seen for all other HRV measures. The inter-rater reliability analyses produced an excellent ICC score (range 0.97-1.00). Comparatively, frequency-domain measures produced higher MDC% and SEM% scores than time-domain and nonlinear measures in both inter- and intra-rater analyses. The Bland-Altman plots revealed relatively higher bias for frequency-domain and nonlinear measures than time-domain measures. ECG-related short-term HRV measures were reliable in injured servicemen under spontaneous breathing. However, the reliability appeared better with the time-domain measure than frequency-domain and nonlinear measures in this sample.

Evaluating the impacts of digital ECG denoising on the interpretive capabilities of healthcare professionals

Abstract Background Electrocardiogram (ECG) interpretation is an essential skill across multiple medical disciplines, yet studies have consistently identified deficiencies in the interpretive performance of healthcare professionals linked to a variety of educational and technological factors. Despite the established correlation between noise interference and erroneous diagnoses, research evaluating the impacts of digital denoising software on clinical ECG interpretation proficiency is lacking. Methods Forty-eight participants from a variety of medical professions and experience levels were prospectively recruited for this study. Participants’ capabilities in classifying common cardiac rhythms were evaluated using a sequential blinded and semi-blinded interpretation protocol on a challenging set of single-lead ECG signals (42 x 10 s) pre- and post-denoising with robust, cloud-based ECG processing software. Results Participants’ ECG rhythm interpretation performance was greatest when raw and denoised signals were viewed in a combined format that enabled comparative evaluation. The combined view resulted in a 4.9% increase in mean rhythm classification accuracy (raw: 75.7% ± 14.5% vs. combined: 80.6% ± 12.5%, p = 0.0087), a 6.2% improvement in mean five-point graded confidence score (raw: 4.05 ± 0.58 vs. combined: 4.30 ± 0.48, p < 0.001), and 9.7% reduction in the mean proportion of undiagnosable data (raw: 14.2% ± 8.2% vs. combined: 4.5% ± 2.4%, p < 0.001), relative to raw signals alone. Participants also had a predominantly positive perception of denoising as it related to revealing previously unseen pathologies, improving ECG readability, and reducing time to diagnosis. Conclusion Our findings have demonstrated that digital denoising software improves the efficacy of rhythm interpretation on single-lead ECGs, particularly when raw and denoised signals are provided in a combined viewing format, warranting further investigation into the impact of such technology on clinical decision-making and patient outcomes.

QRS detection in single-lead, telehealth electrocardiogram signals: Benchmarking open-source algorithms.

A key step in electrocardiogram (ECG) analysis is the detection of QRS complexes, particularly for arrhythmia detection. Telehealth ECGs present a new challenge for automated analysis as they are noisier than traditional clinical ECGs. The aim of this study was to identify the best-performing open-source QRS detector for use with telehealth ECGs. The performance of 18 open-source QRS detectors was assessed on six datasets. These included four datasets of ECGs collected under supervision, and two datasets of telehealth ECGs collected without clinical supervision. The telehealth ECGs, consisting of single-lead ECGs recorded between the hands, included a novel dataset of 479 ECGs collected in the SAFER study of screening for atrial fibrillation (AF). Performance was assessed against manual annotations. A total of 12 QRS detectors performed well on ECGs collected under clinical supervision (F1 score ≥0.96). However, fewer performed well on telehealth ECGs: five performed well on the TELE ECG Database; six performed well on high-quality SAFER data; and performance was poorer on low-quality SAFER data (three QRS detectors achieved F1 of 0.78-0.84). The presence of AF had little impact on performance. The Neurokit and University of New South Wales QRS detectors performed best in this study. These performed sufficiently well on high-quality telehealth ECGs, but not on low-quality ECGs. This demonstrates the need to handle low-quality ECGs appropriately to ensure only ECGs which can be accurately analysed are used for clinical decision making.

Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing

Major gaps in the delivery of appropriate oral anticoagulation therapy (OAC) exist, leaving a large proportion of persons with atrial fibrillation (AF) unnecessarily at risk for stroke and its sequalae. To investigate whether pharmacist-led OAC prescription can increase the delivery of stroke risk reduction therapy in individuals with AF. This prospective, open-label, patient-level randomized clinical trial of early vs delayed pharmacist intervention from January 1, 2019, to December 31, 2022, was performed in 27 community pharmacies in Alberta, Canada. Pharmacists identified patients 65 years or older with 1 additional stroke risk factor and known, untreated AF (OAC nonprescription or OAC suboptimal dosing) or performed screening using a 30-second single-lead electrocardiogram to detect previously unrecognized AF. Patients with undertreated or newly diagnosed AF eligible for OAC therapy were considered to have actionable AF. Data were analyzed from April 3 to November 30, 2023. In the early intervention group, pharmacists prescribed OAC using guideline-based algorithms with follow-up visits at 1 and 3 months. In the delayed intervention group, which served as the usual care control, the primary care physician (PCP) was sent a notification of actionable AF along with a medication list (both enhancement over usual care). After 3 months, patients without OAC optimization in the control group underwent delayed pharmacist intervention. The primary outcome was the difference in the rate of guideline-concordant OAC use in the 2 groups at 3-month follow-up ascertained by a research pharmacist blinded to treatment allocation. Eighty patients were enrolled with actionable AF (9 [11.3%] newly diagnosed in 235 individuals screened). The mean (SD) age was 79.7 (7.4) years, and 45 patients (56.3%) were female. The median CHADS2 (congestive heart failure, hypertension, age, diabetes, and stroke or transient ischemic attack) score was 2 (IQR, 2-3). Seventy patients completed follow-up. Guideline-concordant OAC use at 3 months occurred in 36 of 39 patients (92.3%) in the early intervention group vs 23 of 41 (56.1%) in the control group (P < .001), with an absolute increase of 34% and number needed to treat of 3. Of the 23 patients who received appropriate OAC prescription in the control group, the PCP called the pharmacist for prescribing advice in 6 patients. This randomized clinical trial found that pharmacist OAC prescription is a potentially high-yield opportunity to effectively close gaps in the delivery of stroke risk reduction therapy for AF. Scalability and sustainability of pharmacist OAC prescription will require larger trials demonstrating effectiveness and safety. ClinicalTrials.gov Identifier: NCT03126214.

Smartwatch-Detected Arrhythmias in Patients After Transcatheter Aortic Valve Replacement (TAVR): Analysis of the SMART TAVR Trial.

There are limited data available on the development of arrhythmias in patients at risk of high-degree atrioventricular block (HAVB) or complete heart block (CHB) following transcatheter aortic valve replacement (TAVR). This study aimed to explore the incidence and evolution of arrhythmias by monitoring patients at risk of HAVB or CHB after TAVR using smartwatches. We analyzed 188 consecutive patients in the prospective SMART TAVR (smartwatch-facilitated early discharge in patients undergoing TAVR) trial. Patients were divided into 2 groups according to the risk of HAVB or CHB. Patients were required to trigger a single-lead electrocardiogram (ECG) recording and send it to the Heart Health App via their smartphone. Physicians in the central ECG core lab would then analyze the ECG. The incidence and timing of arrhythmias and pacemaker implantation within a 30-day follow-up were compared. All arrhythmic events were adjudicated in a central ECG core lab. The mean age of the patients was 73.1 (SD 7.3) years, of whom 105 (55.9%) were men. The mean discharge day after TAVR was 2.0 (SD 1.8) days. There were no statistically significant changes in the evolution of atrial fibrillation or atrial flutter, Mobitz I, Mobitz II, and third-degree atrial ventricular block over time in the first month after TAVR. The incidence of the left bundle branch block (LBBB) increased in the first week and decreased in the subsequent 3 weeks significantly (P<.001). Patients at higher risk of HAVB or CHB received more pacemaker implantation after discharge (n=8, 9.6% vs n=2, 1.9%; P=.04). The incidence of LBBB was higher in the group with higher HAVB or CHB risk (n=47, 56.6% vs n=34, 32.4%; P=.001). The independent predictors for pacemaker implantation were age, baseline atrial fibrillation, baseline right bundle branch block, Mobitz II, and third-degree atrioventricular block detected by the smartwatch. Except for LBBB, no change in arrhythmias was observed over time in the first month after TAVR. A higher incidence of pacemaker implantation after discharge was observed in patients at risk of HAVB or CHB. However, Mobitz II and third-degree atrioventricular block detected by the smartwatch during follow-ups were more valuable indicators to predict pacemaker implantation after discharge from the index TAVR. ClinicalTrials.gov NCT04454177; https://clinicaltrials.gov/study/NCT04454177.

Automatic detection of sleep apnea from a single-lead ECG signal based on spiking neural network model

BackgroundSleep apnea (SLA) is a commonly encountered sleep disorder characterized by repetitive cessation of respiration while sleeping. In the past few years, researchers have focused on developing less complex and more cost-effective diagnostic approaches for identifying SLA recipients, in contrast to the cumbersome, complicated, and expensive conventional methods. MethodThis study presents a biologically plausible learning approach of spiking neural networks (SNN) with temporal coding and a tempotron learning model for diagnosing SLA disorder using single-lead electrocardiogram (ECG) data information. The proposed framework utilizes temporal encoding and the leaky integrate and fire model to transform the ECG signal into spikes for capturing the signal's dynamic pattern nature and to simulate input response behaviors. The tempoton learning technique, a spike-based algorithm, trains the SNN model to identify SLA event patterns from encoded output spike trains. This study utilized ECG data to extract heart rate variability (HRV) and ECG-derived respiration (EDR) signals from 1-min segment data of ECG records for input to SNN model. Thirty-five recordings of both released and withheld data from the Apnea-ECG databases from Physionet have been applied to train the SNN model and validate the model's efficacy in identifying SLA occurrences. ResultsThe proposed method demonstrated substantial improvements compared to other SLA detection techniques, achieving a significant accuracy of 94.63 % for per-segment detection, along with specificity, sensitivity, F1-score and AUC values of 96.21 %, 92.04 %, 0.9285, and 0.9851 respectively. The accuracy for per-recording detection achieved 100 %, with a correlation coefficient value of 0.986. Additionally, the experiment used UCD data for validation methods, achieving an accuracy of 84.573 %. ConclusionsThese results suggest the effectiveness and accessibility of the presented approach for accurately identifying SLA cases. The suggested model enhances the performance of SLA detection when contrasted with various techniques based on feature engineering and feature learning.

Detection and severity assessment of obstructive sleep apnea according to deep learning of single-lead electrocardiogram signals.

Developing a convenient detection method is important for diagnosing and treating obstructive sleep apnea. Considering availability and medical reliability, we established a deep-learning model that uses single-lead electrocardiogram signals for obstructive sleep apnea detection and severity assessment. The detection model consisted of signal preprocessing, feature extraction, time-frequency domain information fusion, and classification segments. A total of 375 patients who underwent polysomnography were included. The single-lead electrocardiogram signals obtained by polysomnography were used to train, validate and test the model. Moreover, the proposed model performance on a public dataset was compared with the findings of previous studies. In the test set, the accuracy of per-segment and per-recording detection were 82.55% and 85.33%, respectively. The accuracy values for mild, moderate and severe obstructive sleep apnea were 69.33%, 74.67% and 85.33%, respectively. In the public dataset, the accuracy of per-segment detection was 91.66%. A Bland-Altman plot revealed the consistency of true apnea-hypopnea index and predicted apnea-hypopnea index. We confirmed the feasibility of single-lead electrocardiogram signals and deep-learning model for obstructive sleep apnea detection and severity evaluation in both hospital and public datasets. The detection performance is high for patients with obstructive sleep apnea, especially those with severe obstructive sleep apnea.

Accuracy of a Single-Lead ECG Device for Diagnosis of Cardiac Arrhythmias Compared Against Cardiac Electrophysiology Study

Single-lead electrocardiogram (ECG) devices may allow detection and diagnosis of cardiac rhythms. However, data on their accuracy for detecting cardiac arrhythmias beyond atrial fibrillation are limited. We aimed to determine the accuracy of the AliveCor KardiaMobile (AC) (AliveCor Inc, Mountain View, CA, USA) for the diagnosis of arrhythmias against gold standard cardiac electrophysiology study (EPS). Patients undergoing clinically indicated EPS underwent simultaneous rhythm recording with an AC, standard 12-lead ECG, and EP catheters for intracardiac electrograms. Rhythms recorded during EPS were classified based on electrogram, 12-lead ECG, and clinical findings. Blinded reviewers provided differential diagnoses for the single-lead AC tracings; a separate reviewer compared diagnoses made between the AC tracings and EPS findings. In 49 patients, 843 cardiac rhythms were captured during 502 AC recordings. Analysis of tracings containing sinus rhythm (n=273) returned an overall accuracy of 92%, with sensitivity and specificity values of 93% and 92%, respectively. Accuracy for tracings per rhythm was atrial fibrillation 91% (n=51); supraventricular tachycardia accuracy was 89% (n=191), ventricular tachycardia 91% (n=198), ventricular fibrillation 98% (n=11), and asystole 100% (n=5). Accuracy for supraventricular ectopy was 93% (n=28) and for premature ventricular complexes was 91% (n=86). Overall accuracy was 94% for solitary rhythms and 93% in tracings from patients with baseline bundle branch block. When compared against the gold standard EPS diagnosis, the interpretation of arrhythmias recorded by an AliveCor single-lead ECG device had reasonable diagnostic accuracy.

Supervised Machine Learning to Examine Factors Associated with Respiratory Sinus Arrhythmias and Ectopic Heart Beats in Adults: A Pilot Study

Background: There are many types of arrhythmias which may threaten health that are well-known or opaque. The purpose of this pilot study was to examine how different cardiac health risk factors rank together in association with arrhythmias in young, middle-aged, and older adults. Methods: The analytic sample included 101 adults aged 50.6 ± 22.6 years. Several prominent heart-health-related risk factors were self-reported. Mean arterial pressure and body mass index were collected using standard procedures. Hydraulic handgrip dynamometry measured strength capacity. A 6 min single-lead electrocardiogram evaluated arrhythmias. Respiratory sinus arrhythmias (RSAs) and ectopic heart beats were observed and specified for analyses. Classification and Regression Tree analyses were employed. Results: A mean arterial pressure ≥ 104 mmHg was the first level predictor for ectopic beats, while age ≥ 41 years was the first level predictor for RSAs. Age, heart rate, stress and anxiety, and physical activity emerged as important variables for ectopic beats (p &lt; 0.05), whereas age, sodium, heart rate, and gender were important for RSAs (p &lt; 0.05). Conclusions: RSAs and ectopic arrhythmias may have unique modifiable and non-modifiable factors that may help in understanding their etiology for prevention and treatment as appropriate across the lifespan.

Weighted Dual-Channel Model for Arrhythmia Detection using Single Electrocardiogram Signal

The single-lead method plays a central role in arrhythmia warning, and its anomaly detection is of practical significance for the prevention of heart diseases. However, the detection performance is often limited due to the limited information content of single-lead electrocardiogram (ECG) signals. To address this issue, this paper proposes a weighted dualchannel arrhythmia classification model aimed at improving the detection performance of single-lead ECG signals. The model employs a parallel structure of CNN-LSTM and Transformer to capture both local and global features of the ECG signals. By applying weighted learning to the features from the two channels, the model achieves precise arrhythmia classification. Additionally, to alleviate the class imbalance problem, a weighted cross-entropy loss function is introduced, further enhancing the classification performance. Experimental results based on the MIT-BIH arrhythmia database demonstrate that the proposed model exhibits excellent performance in terms of overall accuracy, F1 score, and sensitivity, achieving 99.33%, 94.71%, and 99.33%, respectively. Compared with existing classification models, the proposed model shows superior classification performance and significant practical value, providing solid technical support for the auxiliary diagnosis of arrhythmias and bringing new possibilities for actual clinical applications.

Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER feasibility study.

Single-lead electrocardiograms (ECGs) can be recorded using widely available devices such as smartwatches and handheld ECG recorders. Such devices have been approved for atrial fibrillation (AF) detection. However, little evidence exists on the reliability of single-lead ECG interpretation. We aimed to assess the level of agreement on detection of AF by independent cardiologists interpreting single-lead ECGs and to identify factors influencing agreement. In a population-based AF screening study, adults aged ≥65 years old recorded four single-lead ECGs per day for 1-4 weeks using a handheld ECG recorder. Electrocardiograms showing signs of possible AF were identified by a nurse, aided by an automated algorithm. These were reviewed by two independent cardiologists who assigned participant- and ECG-level diagnoses. Inter-rater reliability of AF diagnosis was calculated using linear weighted Cohen's kappa (κw). Out of 2141 participants and 162 515 ECGs, only 1843 ECGs from 185 participants were reviewed by both cardiologists. Agreement was moderate: κw = 0.48 (95% confidence interval, 0.37-0.58) at participant level and κw = 0.58 (0.53-0.62) at ECG level. At participant level, agreement was associated with the number of adequate-quality ECGs recorded, with higher agreement in participants who recorded at least 67 adequate-quality ECGs. At ECG level, agreement was associated with ECG quality and whether ECGs exhibited algorithm-identified possible AF. Inter-rater reliability of AF diagnosis from single-lead ECGs was found to be moderate in older adults. Strategies to improve reliability might include participant and cardiologist training and designing AF detection programmes to obtain sufficient ECGs for reliable diagnoses.

Classification of Cardiovascular Arrhythmia Using Deep Learning Techniques: A Review

Deep Learning (DL), an offshoot of Machine Learning (ML) has emerged as a powerful and feasible solution for medical image analysis due to advancements in robust computer software and hardware technologies. It plays a key role in Cardiovascular disease (CVD) diagnosis by detecting anomalies in Electrocardiogram (ECG) signals. Cardiac arrhythmia, which refers to irregular heartbeat, may signal an early symptom of CVD and can lead to fatal outcomes if ignored. Accurate detection of arrhythmia is very challenging even for experts to distinguish between acute and chronic conditions in ECG readings. This triggered the focus of researchers to explore the application of Artificial Intelligence for ECG classification. Traditional machine learning methods use handcrafted features that require domain knowledge. The new era in DL makes the automatic detection of Cardiovascular Disease (CVD) possible. In this paper, an exhaustive review of DL-based techniques for ECG classification has been presented. Research findings in this survey indicate the challenges and issues with arrhythmia detection, such as single lead and multiple lead ECG signals, choice of the size of the training data set, and the number of arrhythmia classes, etc. The study also signifies that there is great scope for improving the performance of arrhythmia prediction models by employing hybrid ensemble learning, time series analysis using Recurrent Neural Network architectures and identification of unexplored classes of arrhythmia.

From Sleep Patterns to Heart Rhythms: Predicting Atrial Fibrillation from Overnight Polysomnograms.

Atrial fibrillation (AF) is often asymptomatic and thus under-observed. Given the high risks of stroke and heart failure among patients with AF, early prediction and effective management are crucial. Importantly, obstructive sleep apnea is highly prevalent among AF patients (60-90%); therefore, electrocardiogram (ECG) analysis from polysomnography (PSG), a standard diagnostic tool for subjects with suspected sleep apnea, presents a unique opportunity for the early prediction of AF. Our goal is to identify individuals at a high risk of developing AF in the future from a single-lead ECG recorded during standard PSGs. We analyzed 18,782 single-lead ECG recordings from 13,609 subjects at Massachusetts General Hospital, identifying AF presence using ICD-9/10 codes in medical records. Our dataset comprises 15,913 recordings without a medical record for AF and 2,056 recordings from patients who were first diagnosed with AF between 1 day to 15 years after the PSG recording. The PSG data were partitioned into training, validation, and test cohorts. In the first phase, a signal quality index (SQI) was calculated in 30-second windows and those with SQI < 0.95 were removed. From each remaining window, 150 hand-crafted features were extracted from time, frequency, time-frequency domains, and phase-space reconstructions of the ECG. A compilation of 12 statistical features summarized these window-specific features per recording, resulting in 1,800 features. We then updated a pre-trained deep neural network and data from the PhysioNet Challenge 2021 using transfer-learning to discriminate between recordings with and without AF using the same Challenge data. The model was applied to the PSG ECGs in 16-second windows to generate the probability of AF for each window. From the resultant probability sequence, 13 statistical features were extracted. Subsequently, we trained a shallow neural network to predict future AF using the extracted ECG and probability features. On the test set, our model demonstrated a sensitivity of 0.67, specificity of 0.81, and precision of 0.3 for predicting AF. Further, survival analysis for AF outcomes, using the log-rank test, revealed a hazard ratio of 8.36 (p-value of 1.93 × 10 -52 ). Our proposed ECG analysis method, utilizing overnight PSG data, shows promise in AF prediction despite a modest precision indicating the presence of false positive cases. This approach could potentially enable low-cost screening and proactive treatment for high-risk patients. Ongoing refinement, such as integrating additional physiological parameters could significantly reduce false positives, enhancing its clinical utility and accuracy.

Diagnostic performance of single-lead electrocardiograms for arterial hypertension diagnosis: a machine learning approach

Diagnostic performance of single-lead electrocardiograms for arterial hypertension diagnosis: a machine learning approach

Single Lead Electrocardiogram Based User Authentication Using Vision Transformer

Single Lead Electrocardiogram Based User Authentication Using Vision Transformer

Enhancement of single-lead dry-electrode ECG through wavelet denoising

Neonatal electrocardiogram (ECG) monitoring is an important diagnostic tool for identifying cardiac issues in infants at birth. Long-term remote neonatal dry-electrode ECG monitoring solutions can be an additional step for preventive healthcare measures. In these solutions, power and computationally efficient embedded signal processing techniques for denoising newborn ECGs can assist in increasing neonatal medical wearable time. Wavelet denoising is an appropriate denoising mechanism with low computational complexity that can be implemented on embedded microcontrollers for long-term remote ECG monitoring. Discrete wavelet transform (DWT) denoising for neonatal dry-electrode ECG using different wavelet families is investigated. The wavelet families and mother wavelets used include Daubechies (db1, db2, db3, db4, and db6), symlets (sym5), and coiflets (coif5). Different levels of added white Gaussian noise (AWGN) were added to 19 newborn ECG signals, and denoising was performed to select the appropriate wavelets for neonatal dry-electrode ECG. The selected wavelets then undergo real noise additions of baseline wander and electrode motion to determine their robustness and accuracy. Signal-to-noise ratio (SNR), mean squared error (MSE), and power spectral density (PSD) are used to examine denoising performance. db1, db2, and db3 wavelets are eliminated from analysis where the 30 dB AWGN led to negative SNR improvement for at least one newborn ECG, removing important ECG information. db4 and sym5 are eliminated from selection due to their different waveform morphology compared to the dry-electrode newborn ECG’s QRS complex. db6 and coif5 are selected due to their highest SNR improvement and lowest MSE of 6.26 × 10−6 and 1.65 × 10−7 compared to other wavelets, respectively. Their wavelet shapes are more like a newborn ECG’s QRS morphology, validating their selection. db6 and coif5 showed similar denoising performance, decreasing electrode motion and baseline wander noisy ECG signals by 10 dB and 14 dB, respectively. Further denoising of inherent dry-electrode noise is observed. DWT with coif5 or db6 wavelets is appropriate for denoising newborn dry-electrode ECGs for long-term neonatal dry-electrode ECG monitoring solutions under different noise types. Their similarity to newborn dry-electrode ECGs yields accurate and robust reconstructed denoised newborn dry-electrode ECG signals.

Comparison Between a Single-Lead ECG Garment Device and a Holter Monitor: A Signal Quality Assessment.

Wearable electronics are increasingly common and useful as health monitoring devices, many of which feature the ability to record a single-lead electrocardiogram (ECG). However, recording the ECG commonly requires the user to touch the device to complete the lead circuit, which prevents continuous data acquisition. An alternative approach to enable continuous monitoring without user initiation is to embed the leads in a garment. This study assessed ECG data obtained from the YouCare device (a novel sensorized garment) via comparison with a conventional Holter monitor. A cohort of thirty patients (age range: 20-82 years; 16 females and 14 males) were enrolled and monitored for twenty-four hours with both the YouCare device and a Holter monitor. ECG data from both devices were qualitatively assessed by a panel of three expert cardiologists and quantitatively analyzed using specialized software. Patients also responded to a survey about the comfort of the YouCare device as compared to the Holter monitor. The YouCare device was assessed to have 70% of its ECG signals as "Good", 12% as "Acceptable", and 18% as "Not Readable". The R-wave, independently recorded by the YouCare device and Holter monitor, were synchronized within measurement error during 99.4% of cardiac cycles. In addition, patients found the YouCare device more comfortable than the Holter monitor (comfortable 22 vs. 5 and uncomfortable 1 vs. 18, respectively). Therefore, the quality of ECG data collected from the garment-based device was comparable to a Holter monitor when the signal was sufficiently acquired, and the garment was also comfortable.

Using Artificial Intelligence to Predict Heart Failure Risk from Single-lead Electrocardiographic Signals: A Multinational Assessment.

Despite the availability of disease-modifying therapies, scalable strategies for heart failure (HF) risk stratification remain elusive. Portable devices capable of recording single-lead electrocardiograms (ECGs) can enable large-scale community-based risk assessment. To evaluate an artificial intelligence (AI) algorithm to predict HF risk from noisy single-lead ECGs. Multicohort study. Retrospective cohort of individuals with outpatient ECGs in the integrated Yale New Haven Health System (YNHHS) and prospective population-based cohorts of UK Biobank (UKB) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Individuals without HF at baseline. AI-ECG-defined risk of left ventricular systolic dysfunction (LVSD). Among individuals with ECGs, we isolated lead I ECGs and deployed a noise-adapted AI-ECG model trained to identify LVSD. We evaluated the association of the model probability with new-onset HF, defined as the first HF hospitalization. We compared the discrimination of AI-ECG against the pooled cohort equations to prevent HF (PCP-HF) score for new-onset HF using Harrel's C-statistic, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). There were 194,340 YNHHS patients (age 56 years [IQR, 41-69], 112,082 women [58%]), 42,741 UKB participants (65 years [59-71], 21,795 women [52%]), and 13,454 ELSA-Brasil participants (56 years [41-69], 7,348 women [55%]) with baseline ECGs. A total of 3,929 developed HF in YNHHS over 4.5 years (2.6-6.6), 46 in UKB over 3.1 years (2.1-4.5), and 31 in ELSA-Brasil over 4.2 years (3.7-4.5). A positive AI-ECG screen was associated with a 3- to 7-fold higher risk for HF, and each 0.1 increment in the model probability portended a 27-65% higher hazard across cohorts, independent of age, sex, comorbidities, and competing risk of death. AI-ECG's discrimination for new-onset HF was 0.725 in YNHHS, 0.792 in UKB, and 0.833 in ELSA-Brasil. Across cohorts, incorporating AI-ECG predictions in addition to PCP-HF resulted in improved Harrel's C-statistic (Δ=0.112-0.114), with an IDI of 0.078-0.238 and an NRI of 20.1%-48.8% for AI-ECG vs. PCP-HF. Across multinational cohorts, a noise-adapted AI model with lead I ECGs as the sole input defined HF risk, representing a scalable portable and wearable device-based HF risk-stratification strategy.